These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17447208)

  • 21. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
    Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.
    Nicholson RI; Staka C; Boyns F; Hutcheson IR; Gee JM
    Endocr Relat Cancer; 2004 Dec; 11(4):623-41. PubMed ID: 15613443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New concepts on hormone dependence in breast cancer].
    Levin E; Caruso SP; Actis AM; de Levin RW
    Medicina (B Aires); 1997; 57(1):95-103. PubMed ID: 9435378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor mechanisms mediating non-genomic actions of sex steroids.
    Boonyaratanakornkit V; Edwards DP
    Semin Reprod Med; 2007 May; 25(3):139-53. PubMed ID: 17447204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor.
    Boonyaratanakornkit V
    Steroids; 2011 Aug; 76(9):877-84. PubMed ID: 21354435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Growth control of breast cancer in relation to hormones].
    Tominaga T; Yoshida Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3685-90. PubMed ID: 2688558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to endocrine therapy in breast cancer.
    Kurebayashi J
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():39-46. PubMed ID: 16273353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staying the distance: avoiding the proteasomal trap.
    Downes M; Evans RM
    Cancer Cell; 2008 Mar; 13(3):184-5. PubMed ID: 18328421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane-initiated signaling of estrogen in the brain.
    Rønnekleiv OK; Malyala A; Kelly MJ
    Semin Reprod Med; 2007 May; 25(3):165-77. PubMed ID: 17447206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.
    Márquez DC; Chen HW; Curran EM; Welshons WV; Pietras RJ
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):91-100. PubMed ID: 16388889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
    McCafferty MP; McNeill RE; Miller N; Kerin MJ
    Breast Cancer Res Treat; 2009 Aug; 116(3):425-32. PubMed ID: 19507020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?
    Sheikh MS; Garcia M; Pujol P; Fontana JA; Rochefort H
    Invasion Metastasis; 1994-1995; 14(1-6):329-36. PubMed ID: 7657526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
    Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
    Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex hormone receptors in breast cancer.
    D'Abreo N; Hindenburg AA
    Vitam Horm; 2013; 93():99-133. PubMed ID: 23810004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing the efficacy of hormonal agents with selected targeted agents.
    Johnston SR
    Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S28-36. PubMed ID: 19561004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.